AzTrials
AzTrials

Insufficient Bone Mass in the Maxilla for Dental ImplantsPhase 1DKK SVPNCT01204424

Clinical Investigation to Assess the Safety and Feasibility of the Crestal, Minimal-invasive Sinus Floor Augmentation With the Pressure Chamber Drill (DKK) and the Sinus Vibration Pump (SVP)

A Phase 1 study testing minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.) and minimal invasive crestal sinus lift with the JEDER Systh. in people with Insufficient Bone Mass in the Maxilla for Dental Implants, run by Jeder GmbH at 1 site in Austria.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The success of dental implants is based on a variety of factors including; surgical technique, health of the patient, operator skill and, to a significant part, sufficient bone for the placement and integration of dental implants. Read more about this study

Who is it for?
Ages 18 to 90 years
What is being tested?
minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.) and minimal invasive crestal sinus lift with the JEDER Systh.
Type of treatment
Medical device
How many people
20 participants
Where
1 siteAustria
Study dates
Sep 2010to Jun 2011
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • demand for sinus floor elevation (regio 4 to 7)
  • loss of teeth (regio 4 to 7)
  • needed extraction of teeth (regio 4 to 7)

Who cannot join

  • maxillary bone mass <3mm
  • severe chronic illness or immune deficiency
  • cortisone therapy
  • sinus membrane membrane hight >5mm
  • chronic sinusitis
  • smoking >20 Zigarettes
  • missing dental hygiene

Trial locations and contacts

1 site in 1 country.

Andreas Bayerle, MBA contact

abayerle@yahoo.com

Michaela Bayerle-Eder, Prof., contact

michaela.bayerle-eder@meduniwien.ac.at

Austria1 site, 1 recruiting
  • Ordination Dr. Klaus Eder

    Vienna, State of Vienna, 1130

    Recruiting

Other trials in Austria

About this study

Official title: Klinische Prüfung Zur Untersuchung Der Sicherheit Und Machbarkeit Des Crestalen, Minimal-invasiven Kieferknochenaufbaus (Sinuslift) Mit Der Druck-kammerknochenfräse (DDK) Und Der Sinusvibrationspumpe (SVP)

The success of dental implants is based on a variety of factors including; surgical technique, health of the patient, operator skill and, to a significant part, sufficient bone for the placement and integration of dental implants. To that end, the replacement of the maxillary posterior teeth have presented a considerable challenge because, after the loss of maxillary posterior teeth the quality and quantity of the remaining supporting bone may be insufficient to support implants properly or reliably. To overcome the deficiency of insufficient vertical bone mass of the maxilla, several surgical techniques have been developed to increase available bone mass for the replacement of dental implants by bone augmentation.

The conventional procedure for a sinus lift (Caldwell-Luc procedure) requires preparation of a mucoperiosteal flap in the buccal molar region and to cut an oval window in the thus exposed bone, without damage to the subjacent maxillary sinus membrane. The procedure is very invasive and subjects the patient to great stress as a result of substantial swelling and discoloration of up to 10 days, and possibly of pain. This surgical procedure is oftentimes referred to as "open" or "classic" sinus lift. This technique is fraught with many risks and complications because of the limitations of healing potential in the maxillary sinus. In spite of these risks many patients undergo this procedure because of the strong desire to replace missing maxillary teeth with dental implants.

Read more

An alternative approach to the maxillary sinus from the inferior approach of the alveolar ridge utilizing solid cylindrical osteotomes was described by Dr. Summers (crestal sinus lift). It is a more conservative approach and is less invasive. It was developed to eliminate the risks described above.While this technique is safer, an overzealous use of an osteotome during the placement of the regenerative material can result in the perforation of the subantral membrane with disadvantages discussed above.

Dr. Eder has developed an innovative way - the JEDER System - of carrying out a crestal sinus lift that substantially reduces the risk of perforating the subantral membrane. This minimal- invasive way uses 2 newly developed and successfully patented instruments, the "Druckkammerknochenfräse" DKK and the "Sinusvibrationspumpe" SVP. Following JEDER Syst. the mucous membrane of the mouth is opened from the toothless part of the maxillary crest up to the bone and the bone is scraped by a cylindrical cutter in the shape of a tunnel up to slightly underneath the maxillary sinus membrane.

The aim of the study is to assess the efficacy and safety of the JEDER Syst., which was already demonstrated in 50 treatment attempts. The results of this study will be used for the certification process to enable the declaration of conformity for the market approval.

The main outcome parameter is the perforation rate of the subantral membrane intraoperatively and within 6 weeks after the operation.

Risk benefit assessment:

In the present study there will be no additional examinations undertaken compared to patients which undergo the conventional procedure. The conventional procedure is associated with a risk of membrane perforation and consecutive diseases like infection, swelling and pain. All these inconveniences should be avoided by using the JEDER Syst. If the worst case scenario - the perforation of the subantral membrane - happens, the conventional method will be used. Therefore, the risk-benefit assessment

Being tested
minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.), minimal invasive crestal sinus lift with the JEDER Systh.
Keywords
minimal invasive, sinus floor augmentation, sinuslift, dental implants

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.)Device

    minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.)

  • minimal invasive crestal sinus lift with the JEDER Systh.Device

    Also called minimal invasive crestal sinuslift

    The mucous membrane is opened from the toothless part of the maxillary crest up to the bone and the bone is scraped by a cylindrical cutter in the shape of a tunnel up to slightly underneath the maxillary sinus membrane and hydraulic pressure is being built up within the DKK. A centrally placed drill within the DKK slowly moves in the direction of the membrane. At the moment of the first minimal perforation of the remaining bone the pressurized fluid pushes the membrane back and ensures that the membrane is not perforated by the drill.

    The SVP is used to generate hydraulic vibrations, which help to further raise the membrane from the bone (principle of the "percussion drill"). After the maxillary sinus membrane has successfully been elevated, the working fluid is extracted and bone replacement material is introduced via the bore.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. perforation rate of the subantral membrane in the sinus maxillaris

    Measured: intraoperativ and within 6 weeks after the operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2010 (estimated)
  2. Study startSep 2010
  3. Primary completionMar 2011 (estimated)
  4. Study completionJun 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01204424
Sponsor's protocol ID
DKK-SVP-10 Prot. 1.4
Other IDs
EK_10_101_0610
Acronym
DKK SVP
Status last verified
Sep 2010
First submitted
16 Sep 2010
Last updated
17 Sep 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing minimal-invasive sinus floor augmentation with the DKK and SVP (JEDER Syst.) and minimal invasive crestal sinus lift with the JEDER Systh. in people with Insufficient Bone Mass in the Maxilla for Dental Implants, run by Jeder GmbH at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Sep 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Andreas Bayerle, MBA (abayerle@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

perforation rate of the subantral membrane in the sinus maxillaris (time frame: intraoperativ and within 6 weeks after the operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2010; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in